Source of pharmaceutical innovation classified by location of the company headquarters by (a) country of the inventor and (b) patent assignees: 1992–2004.
Note. Data based on drugs approved between 1992 and 2004. The sample size was N = 346. Other includes Denmark, Spain, Norway, Austria, Korea, Czechoslovakia, and Australia. Percentages do not add up to 100% because of rounding,